Aegerion Pharmaceuticals, Inc. - FORM S-1 - EX-23.2 - CONSENT OF ERNST & YOUNG LLP - June 16, 2011

Attached files

file filename
S-1 - FORM S-1 - Aegerion Pharmaceuticals, Inc.ds1.htm
EX-5.1 - OPINION OF GOODWIN PROCTER LLP - Aegerion Pharmaceuticals, Inc.dex51.htm
EX-23.1 - CONSENT OF L.E.K. CONSULTING, LLC - Aegerion Pharmaceuticals, Inc.dex231.htm

Exhibit 23.2

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 31, 2011, in the Registration Statement (Form S-1) and related Prospectus of Aegerion Pharmaceuticals, Inc. for the registration of shares of its common stock, to be filed with the Securities and Exchange Commission on or about June 16, 2011.

/s/ Ernst & Young LLP

MetroPark, New Jersey

June 16, 2011

Aegerion Pharmaceuticals, Inc. Reports

Also read